These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2073118)

  • 21. In vitro activity of tigecycline in combination with cefoperazone-sulbactam against multidrug-resistant Acinetobacter baumannii.
    Liu B; Bai Y; Liu Y; Di X; Zhang X; Wang R; Wang J
    J Chemother; 2015 Oct; 27(5):271-6. PubMed ID: 25068186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [In vitro antibacterial activity of cefoperazone-sulbactam].
    Zhang Y; Zhang J; Zhou L
    Zhonghua Nei Ke Za Zhi; 1995 Oct; 34(10):676-9. PubMed ID: 8731829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Synergy between sulbactam and ampicillin or cefoperazone in antimicrobial activity against beta-lactamase producing microorganisms. Results with the use of microdilution broth method].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukushima Y; Fukayama S; Ishihara R; Oda S; Tanaka S; Sato K
    Jpn J Antibiot; 1990 Jul; 43(7):1214-24. PubMed ID: 2232151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In-vitro antimicrobial studies with the combination of cefoperazone and sulbactam.
    Greenberg RN; Baker M; Meade DW; Chang Y; Danko LS
    J Antimicrob Chemother; 1993 Dec; 32(6):912-3. PubMed ID: 8144438
    [No Abstract]   [Full Text] [Related]  

  • 25. In-vitro activity of cefoperazone-sulbactam combination against cefoperazone resistant clinical isolates in a Malaysian general hospital.
    Lim VK; Cheong YM
    Malays J Pathol; 1995 Dec; 17(2):73-6. PubMed ID: 8935129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multicenter evaluation of antimicrobial resistance to six broad-spectrum beta-lactams in Colombia using the Etest method. The Colombian Antimicrobial Resistance Study Group.
    Jones RN; Salazar JC; Pfaller MA; Doern GV
    Diagn Microbiol Infect Dis; 1997 Dec; 29(4):265-72. PubMed ID: 9458984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of beta-lactamase inhibitors on the antimicrobial activity of cefoperazone, cefotaxime, and ceftizoxime against aerobic and anaerobic beta-lactamase producing bacteria.
    Fuchs PC; Jones RN; Barry AL
    Diagn Microbiol Infect Dis; 1987 Sep; 8(1):61-5. PubMed ID: 3501975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In-vitro susceptibility of cefoperazone-susceptible and -resistant gram-negative rods to cefoperazone plus sulbactam, other beta-lactams, aminoglycosides and quinolone.
    Chandrasekar PH; Sluchak JA
    Infection; 1991; 19(1):49-53. PubMed ID: 2013510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The reliability of using impenem, meropenem, cefoperazone-sulbactam and piperacillin-tazobactam to treat nosocomial Gram-negative bacterial infections with Monte Carlo simulation].
    Xiao YH; Hu YJ
    Zhonghua Nei Ke Za Zhi; 2017 Aug; 56(8):595-600. PubMed ID: 28789493
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparison of commonly used antimicrobial susceptibility testing methods for evaluating susceptibilities of clinical isolates of Enterobacteriaceae and nonfermentative Gram-negative bacilli to cefoperazone-sulbactam.
    Jean SS; Liao CH; Sheng WH; Lee WS; Hsueh PR
    J Microbiol Immunol Infect; 2017 Aug; 50(4):454-463. PubMed ID: 26454423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Combined effect of sulbactam/cefoperazone and other antibiotics against clinical isolates of multi-resistant strains. I. Effect of sulbactam against beta-lactams resistant strains and in vitro combined effect of sulbactam/cefoperazone with each of piperacillin, latamoxef, ceftazidime, fosfomycin and doxycycline].
    Kouda M; Kumagai I; Kobayashi J; Sugai R; Matsuzaki H
    Jpn J Antibiot; 1990 Apr; 43(4):636-58. PubMed ID: 2199689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antimicrobial activity of sulbactam/cefoperazone. Comparison with other new cephems].
    Deguchi K; Yokota N; Koguchi M; Fukayama S; Nishimura Y; Nakane Y; Oda S; Tanaka S; Kato M; Sato K
    Jpn J Antibiot; 1987 Oct; 40(10):1752-61. PubMed ID: 3444015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multicentre study on antibiotic susceptibilities of anaerobic bacteria to cefoperazone-sulbactam and other antimicrobial agents.
    Clark RB; Bartelt MA; Chan EL; Dalton HP
    J Antimicrob Chemother; 1992 Jan; 29(1):57-67. PubMed ID: 1737725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resistance to cefoperazone-sulbactam in Klebsiella pneumoniae: evidence for enhanced resistance resulting from the coexistence of two different resistance mechanisms.
    Rice LB; Carias LL; Etter L; Shlaes DM
    Antimicrob Agents Chemother; 1993 May; 37(5):1061-4. PubMed ID: 8390809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [In vitro activity of beta-lactam antibiotics in combination with sulbactam against enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter. Results of a multicenter study].
    Kazmierczak A; Siebor E; Acar JF; Denis F; Drugeon H; Fleurette J; Sirot J; Soussy CJ; Thabaut A
    Pathol Biol (Paris); 1991 May; 39(5):384-90. PubMed ID: 1909015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of inoculum size on the activity of cefoperazone-sulbactam against multidrug resistant organisms.
    Chang PC; Chen CC; Lu YC; Lai CC; Huang HL; Chuang YC; Tang HJ
    J Microbiol Immunol Infect; 2018 Apr; 51(2):207-213. PubMed ID: 29037802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimicrobial activity of cefoperazone with clavulanic acid or sulbactam against Enterobacteriaceae.
    Nagy E; Hajdu E; Földes J
    J Antimicrob Chemother; 1990 Apr; 25(4):701-3. PubMed ID: 2351631
    [No Abstract]   [Full Text] [Related]  

  • 38. [In vitro susceptibility to cefoperazone and sulbactam/cefoperazone combination of bacterial strains isolated from various patient materials].
    Aksoy AM; Ozsan M; Ural O; Ekmen H
    Mikrobiyol Bul; 1993 Jul; 27(3):216-20. PubMed ID: 8361410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro activity of beta-lactam drugs and sulbactam against Chlamydia trachomatis.
    Segreti J; Kapell KS; Trenholme GM
    Diagn Microbiol Infect Dis; 1992; 15(4):371-3. PubMed ID: 1611854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [In vitro resistance development in Acinetobacter baumannii to sulbactam and cefoperazone].
    Wieczorek P; Sacha P; Ojdana D; Milewski R; Jurczak A; Kaczyńska K; Tryniszewska E
    Med Dosw Mikrobiol; 2012; 64(1):55-62. PubMed ID: 22808730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.